All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for BIOSPLICE THERAPEUTICS, INC. · Pharmaceutical company.

Filing Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$70,000.00

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 4

Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; Issues related to appropriations report language for Fiscal Year 2027.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.